Hedde D Biesma
Overview
Explore the profile of Hedde D Biesma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soeratram T, Biesma H, Egthuijsen J, Meershoek-Klein Kranenbarg E, Hartgrink H, van de Velde C, et al.
Mod Pathol
. 2023 May;
36(9):100218.
PMID: 37182582
Tumor-infiltrating lymphocytes are associated with the survival of gastric cancer patients. T-cell densities in the tumor and its periphery were previously identified as prognostic T-cell markers for resectable gastric cancer....
2.
Quaas A, Biesma H, Wagner A, Verheij M, van Berge Henegouwen M, Schoemig-Markiefka B, et al.
Eur J Cancer
. 2022 Jul;
173:95-104.
PMID: 35863110
Objective: Biological sex differences in cancer are increasingly acknowledged. Here, we examined these differences in clinicopathological characteristics and survival in microsatellite instability (MSI)-high and microsatellite stable (MSS) gastric cancer (GC)....
3.
Biesma H, Soeratram T, Sikorska K, Caspers I, van Essen H, Egthuijsen J, et al.
Gastric Cancer
. 2022 Feb;
25(3):640-651.
PMID: 35129727
Background: Epstein-Barr virus positivity (EBV+) and microsatellite instability (MSI-high) are positive prognostic factors for survival in resectable gastric cancer (GC). However, benefit of perioperative treatment in patients with MSI-high tumors...
4.
van Dijk E, Biesma H, Cordes M, Smeets D, Neerincx M, Das S, et al.
J Clin Oncol
. 2018 May;
36(20):2052-2060.
PMID: 29792754
Purpose Patients with metastatic colorectal cancer (mCRC) have limited benefit from the addition of bevacizumab to standard chemotherapy. However, a subset probably benefits substantially, highlighting an unmet clinical need for...
5.
Biesma H, Schouten P, Lacle M, Sanders J, Brugman W, Kerkhoven R, et al.
Genes Chromosomes Cancer
. 2015 Sep;
54(12):734-44.
PMID: 26355282
Genomic aberrations can be used to subtype breast cancer. In this study, we investigated DNA copy number (CN) profiles of 69 cases of male breast cancer (MBC) by array comparative...